Lonza (Greenwood, SC) has been granted U.S. Patent 10,016,382 for its L-carnitine’s use in pet food to support performance and recovery in active dogs.
Lonza (Greenwood, SC) has been granted U.S. Patent 10,016,382 for its L-carnitine’s use in pet food to support performance and recovery in active dogs. L-carnitine reduces muscle degradation and oxidative stress from intense physical activity, helping to maintain lean muscle mass. The patent confirms evidence that small daily doses of Lonza’s branded L-carnitine, Carniking, may enhance the quality of life and function of active dogs and working animals such as service dogs and tracking dogs.
“Bringing together 30 years of investment and discovery in L-carnitine, Lonza’s new patent for L-carnitine as Carniking highlights our continued commitment to exploring its health benefits for both animals and humans,” said Kevin Owen, PhD, global business development head- companion animals at Lonza CHN and co-author of the patent, in a press release. “Backed by robust science, the patent confirms that L-carnitine is good for both you and for your dog.”
Prinova acquires Aplinova to further increase its footprint in Latin America
April 7th 2025Prinova has recently announced the acquisition of Brazilian ingredients distributor Aplinova, which is a provider of specialty ingredients for a range of market segments that include food, beverage, supplements, and personal care.